Genes linked to Alzheimer’s risk have been identified
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
List view / Grid view
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
A chaperone protein has been identified as a possible therapeutic target for the treatment of Kennedy's disease and prostate cancer.
Researchers have identified a pathway in the immune system activated in Crohn's disease which could lead to investigating new treatments.
A new drug called IP1867B, which could be used for future treatments of brain tumours, is being examined.
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
A new experiment has not only slowed the progression of the prion disease, scrapie, it also extended the lives of prion-infected mice
New study shows that a subset of follicular helper T cells contributes to the hyposialylation of autoantibodies in rheumatoid arthritis.
New study sheds light on how the TP53 gene becomes mutated and how those mutations can help predict clinical outlooks for cancer.
31 July 2019 | By Fluidic Analytics
Join us as we discuss the latest data from the literature and application studies where diffusional sizing (MDS) is used to assess a variety of protein interactions – even of difficult targets.
Researchers have discovered a new combination therapy to treat drug-resistant acute lymphoblastic leukaemia, tested in pre-clinical trials.
Using human data, a new study has examined how Cryptococcus genes impact patients with Cryptococcus Neoformans.
The so-called 'longevity gene' has been included in animal models, in which it stopped atherosclerosis.
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.
Scientists have discovered a way to improve immune-based treatments by modulating T cells.